NO MEMORY IMAGE ON FILE
CVS · Recalled
CVS Sleep Caplets Recalled by PL
Poisoning
- Units
- Not stated
- Reports
- —
- Injuries
- —
- Deaths
- —
- Price
- —
- Remedy
- See notice
Reports, injuries, deaths and price are read out of the notice’s wording by rules, so they can miss unusual phrasing. The official notice is the record.
Affected
CVS Sleep Caplets Recalled by PL NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE CONTACT: Ken Giles July 25, 1996 (301) 504-7052 Release # 96-171 CPSC and PL Development Announce Recall of CVS Sleep Caplets WASHINGTON, D.C. - In cooperation with the U.S. Consumer Product Safety Commission (CPSC), PL Development Inc. of Farmingdale, N.Y., is voluntarily recalling 3,798 bottles of CVS Sleep Caplets containing diphenhydramine. The bottles lack the child-resistant packaging required by the Poison Prevention Packaging Act. Diphenhydramine is toxic if accidentally ingested by children and can cause them serious injury or be fatal. CPSC, PL Development, and CVS are not aware of any injuries involving this product. This recall is being conducted to prevent the possibility of injury. The recalled product is labeled, "CVS sleep caplets nighttime sleep aid 60 CAPLETS... Active Ingredient: Each caplet contains 25 mg. Diphenhydramine Hydrochloride." The outer box and bottles bear lot numbers D423 or D424. CVS sold 3,798 bottles of these sleeping caplets from February 26, 1996, to March 19,1996, for approximately $3.89 a bottle. CVS removed the bottles without child-resistant caps from its shelves and currently sells the product with appropriate child-resistant closures. These closures are labeled, "SAVE A CHILD, CLOSE TIGHTLY. TO OPEN PUSH DOWN & TURN," and are not under recall. Consumers should stop using the recalled sleep caplets immediately and return the bottle to the store where purchased for an exchange or full refund. For more information, consumers should call PL Development collect at (516) 249-0867. This problem was identified by the Quality Control Department of CVS. PL Development, Inc. voluntarily reported this occurrence to CPSC.
The file
- Sold at
- Not stated
- Product type
- Medication
- Made in
- Not stated
- Recalled by
- CVS, PL Development
Incident log
None stated.
What the notice says to do
See the official notice.
Recall notice published by the U.S. Consumer Product Safety Commission. This site is independent: always confirm on the official notice before acting.